{
    "clinical_study": {
        "@rank": "35013", 
        "arm_group": [
            {
                "arm_group_label": "Off-clamp partial nephrectomy", 
                "arm_group_type": "Experimental", 
                "description": "Partial nephrectomy will be performed without clamping of the renal blood vessels."
            }, 
            {
                "arm_group_label": "Traditional partial nephrectomy", 
                "arm_group_type": "No Intervention", 
                "description": "Partial nephrectomy will be performed with clamping of the renal blood vessels."
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this research study is to compare the effects on kidney function after\n      performing the removal of a kidney tumor with or without clamping the blood vessels during\n      surgery."
        }, 
        "brief_title": "Off Clamp Randomization", 
        "completion_date": {
            "#text": "April 2020", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Renal Cancer", 
            "Renal Ischemia"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Carcinoma, Renal Cell", 
                "Kidney Neoplasms", 
                "Ischemia"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients 18 and older.\n\n          -  Patients willing and able to sign consent.\n\n          -  Patients with an organ confined renal mass planning to undergo a robotic assisted\n             partial nephrectomy (RAPN).\n\n          -  Patient with Karnofsky Performance Status (KPS) equal to or greater than 40.\n\n        Exclusion Criteria:\n\n          -  Patients under 18.\n\n          -  Patients with Karnofsky Performance Status (KPS) less than 40.\n\n          -  Patients with non-organ confined renal masses (invading renal vein, inferior vena\n             cava, peri-renal tissue, ipsilateral adrenal gland, or metastasis).\n\n          -  Patients with bilateral synchronous renal masses.\n\n          -  Patients who can not discontinue Plavix, Coumadin or other anti-platelet or\n             anti-coagulant medications.\n\n          -  Patients with renal lesions determined to be too complex to perform a RAPN without\n             clamp by the surgeon. (The renal mass may be deemed too difficult based on\n             pre-operatively radiological findings. The surgeon's decision to exclude a mass from\n             a robotic assisted partial nephrectomy would be based on a higher risk of positive\n             margin or complication if a RAPN was performed.)"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 16, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01732120", 
            "org_study_id": "myIRB ID 201208091"
        }, 
        "intervention": {
            "arm_group_label": "Off-clamp partial nephrectomy", 
            "intervention_name": "Off-clamp partial nephrectomy", 
            "intervention_type": "Procedure"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "off-clamp", 
            "partial nephrectomy", 
            "renal cancer treatment", 
            "renal ischemia"
        ], 
        "lastchanged_date": "February 17, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "St. Louis", 
                    "country": "United States", 
                    "state": "Missouri", 
                    "zip": "63110"
                }, 
                "name": "Washington University School of Medicine"
            }, 
            "investigator": {
                "last_name": "Robert S Figenshau, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Evaluation of the Off-Clamp Robot-Assisted Partial Nephrectomy Technique in the Management of Renal Tumors", 
        "overall_contact": {
            "email": "klima@wudosis.wuslt.edu", 
            "last_name": "Aleksandra P Klim, MHS", 
            "phone": "314-747-9781"
        }, 
        "overall_contact_backup": {
            "email": "bergeronk@wudosis.wustl.edu", 
            "last_name": "Karla Bergeron", 
            "phone": "314-454-7325"
        }, 
        "overall_official": {
            "affiliation": "Washington University School of Medicine", 
            "last_name": "Robert S Figenshau, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Renal function following nephrectomy with and without clamping will be assessed using:\ndecline in estimated glomerular filtration rate\ndecline in split renal function", 
            "measure": "Renal function", 
            "safety_issue": "No", 
            "time_frame": "3 months post nephrectomy"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01732120"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Oncologic outcomes will be assessed based on:\npathological results\nevidence of disease recurrence or metastasis on follow-up imaging", 
                "measure": "Oncologic outcomes", 
                "safety_issue": "No", 
                "time_frame": "5 years"
            }, 
            {
                "description": "Perioperative outcomes will be assessed based on:\nestimated blood loss\noperative time and warm ischemia time\nintra-operative complications\nlength of postoperative hospital stay\npostoperative complications", 
                "measure": "Perioperative outcomes", 
                "safety_issue": "No", 
                "time_frame": "3 months"
            }
        ], 
        "source": "Washington University School of Medicine", 
        "sponsors": {
            "collaborator": {
                "agency": "Midwest Stone Institute.", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Washington University School of Medicine", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}